These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3623232)

  • 21. Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy.
    Spirtos NM; Gross GM; Freddo JL; Ballon SC
    Gynecol Oncol; 1995 Mar; 56(3):345-52. PubMed ID: 7705667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The clinical significance of retroperitoneal lymph node metastasis and lymphadenectomy on 3-year survival in ovarian carcinoma].
    Takahashi Y; Akiyama M; Hirose M; Yamamoto Y; Tenzaki T; Ishiguro T; Noda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Oct; 45(10):1095-100. PubMed ID: 8245587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should epithelial ovarian carcinoma metastatic to the inguinal lymph nodes be assigned stage IVB?
    Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K
    Gynecol Oncol; 2017 Oct; 147(1):81-84. PubMed ID: 28716307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph node metastasis in stage I epithelial ovarian cancer.
    Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
    Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer.
    Yavuzcan A; Baloglu A; Cetinkaya B
    Arch Gynecol Obstet; 2009 Dec; 280(6):939-44. PubMed ID: 19306011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph node-positive stage IIIC ovarian cancer: a separate entity?
    Berek JS
    Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S18-20. PubMed ID: 19955908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes.
    Uzan C; Morice P; Rey A; Pautier P; Camatte S; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D
    Ann Surg Oncol; 2004 Jul; 11(7):658-64. PubMed ID: 15197013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer.
    Bachmann C; Brucker SY; Kraemer B; Rothmund R; Staebler A; Fend F; Wallwiener D; Grischke EM
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1475-80. PubMed ID: 25739827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An analysis of pelvic and para-aortic lymph node metastasis in ovarian carcinoma by systematic retroperitoneal lymph node dissection].
    Tsumura N; Sakuragi N; Hareyama H; Nomura E; Ohkouchi T; Yamamoto R; Takeda N; Nishiya M; Hirahatake K; Fujino T; Okubo H; Satoh C; Makinoda S; Kawaguchi I; Fujimoto S
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jul; 48(7):508-14. PubMed ID: 8754392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should pelvic and para-aortic lymphadenectomy be different depending on histological subtype in epithelial ovarian cancer?
    Roger N; Zafrani Y; Uzan C; Gouy S; Rey A; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
    Ann Surg Oncol; 2008 Jan; 15(1):333-8. PubMed ID: 17943386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Risk factors for retroperitoneal lymph node metastasis in ovarian cancer].
    Akiyama M; Takahashi Y; Hirose M; Yamamoto Y; Ishiguro T; Noda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Mar; 46(3):260-4. PubMed ID: 8133137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
    Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
    Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in ovarian carcinoma patients after second-look laparotomy.
    Menczer J; Ben-Baruch G; Modan M; Brenner H
    Cancer; 1989 Apr; 63(8):1509-13. PubMed ID: 2924259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary cytoreductive surgery for isolated lymph node recurrence of epithelial ovarian cancer: a multicenter study.
    Ferrero A; Ditto A; Giorda G; Gadducci A; Greggi S; Daniele A; Fuso L; Panuccio E; Scaffa C; Raspagliesi F; Sismondi P; Biglia N
    Eur J Surg Oncol; 2014 Jul; 40(7):891-8. PubMed ID: 24378007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
    Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S
    Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
    Wu LY; Zhang R; Huang MN; Li N; Wang GX; Liu LY
    Ai Zheng; 2003 Apr; 22(4):424-7. PubMed ID: 12704005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The surgical treatment of ovarian cancer].
    Burghardt E; Lahousen M; Stettner H
    Geburtshilfe Frauenheilkd; 1990 Sep; 50(9):670-7. PubMed ID: 2272432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of para-aortic lymph node dissection and prognosis in ovarian cancer.
    Li X; Xing H; Li L; Huang Y; Zhou M; Liu Q; Qin X; He M
    Front Med; 2014 Mar; 8(1):96-100. PubMed ID: 24464488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic results of second-look laporatomy with extensive dissection of retroperitoneal lymph nodes in ovarian cancer patients].
    Wu X; Zhang Z; Tang M
    Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):300-2. PubMed ID: 11776822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.